Weight loss injections without a gallbladder: what you need to know before you start

Step 1: what your prescriber needs to know before treatment

The first step is a straightforward one: tell us. Whether you had your gallbladder removed last year or two decades ago, your prescriber needs that detail on record before approving any GLP-1 medicine. This is not a barrier (for most people who have had a cholecystectomy, treatment is perfectly workable) but it shapes the clinical conversation.

A prescriber reviewing your case will also want to know whether you experienced any complications after removal: ongoing bile duct problems, post-cholecystectomy syndrome (loose stools, bloating, upper abdominal discomfort), or any history of bile duct stones. GLP-1 medicines already have a gastrointestinal side-effect profile, so understanding your baseline matters. At our pharmacy, every consultation is read by a real GPhC-registered prescriber, not a set of automated rules, so nuances like this are caught and considered. You can see more about our clinical team at our clinical team page.

If your history is more complex (recent bile duct surgery, active liver disease, or an existing bile acid condition) expect a more detailed clinical exchange. The prescriber may ask follow-up questions before confirming suitability, and if you are new to this area, our page explaining how a weight loss injection works is a helpful place to build that understanding before your consultation. Our page on using weight loss injections with no gall bladder covers the specific considerations for people in this situation.

Step 2: understanding what changes when there is no gallbladder

The gallbladder's job is to store bile produced by the liver and release it in concentrated bursts when fat arrives in the small intestine. After removal, bile drips continuously from the liver into the duodenum rather than being released in response to a meal. This is usually manageable, though some people notice looser stools or digestive sensitivity, particularly with fatty food.

GLP-1 medicines slow gastric emptying, meaning food (and fat) moves through the stomach more gradually. For some people without a gallbladder, this altered timing can interact with the continuous bile drip in a way that affects digestion. It does not make the medicine unsafe, but it can influence how GI side effects feel, particularly in the early weeks of treatment. The NHS tirzepatide page outlines the expected gastrointestinal effects in plain language; the side-effect profile for semaglutide is similar.

There is also the broader question of gallstone risk during rapid weight loss. When weight falls quickly, cholesterol saturation in bile can rise, increasing stone-forming risk in the bile ducts even after the gallbladder itself is gone. GLP-1 medicines typically produce weight loss more gradually than crash dieting, which reduces this risk somewhat, but gradual is relative. A protein-adequate diet, staying hydrated, and avoiding very low-fat eating can all help. If you want to understand how these medicines interact with gallbladder health specifically, our page on weight loss injections and the gallbladder explains the relationship in detail.

Step 3: symptoms that mean stop and seek help

This is the section to read carefully. A small number of people on GLP-1 medicines experience gallbladder-related complications even with an intact gallbladder; for those without one, the relevant risk shifts to the bile ducts.

Get medical help promptly (call your GP or 111, or go to A&E if symptoms are severe) if you experience any of the following: severe or persistent pain in your upper right abdomen or centre of your stomach; pain that spreads to your back or right shoulder; yellowing of the skin or whites of the eyes (jaundice); dark urine or pale stools; a high temperature with shaking or chills. These can signal bile duct obstruction or infection and need urgent assessment. Do not wait to see if symptoms settle.

In January 2026, the MHRA issued a Drug Safety Update for GLP-1 medicines flagging acute pancreatitis as a known, though infrequent, serious side effect. Symptoms overlap with biliary problems: severe, persistent stomach pain, sometimes reaching through to the back, with or without vomiting. Again, prompt medical attention is the right call. You can report any suspected side effect via the Yellow Card scheme; this helps the MHRA monitor emerging patterns.

For a broader picture of how these medicines relate to gallbladder health more generally, our page on whether weight loss injections cause gallbladder problems covers the evidence on this in full. You can also read our dedicated page on weight loss injections and gallbladder issues for a closer look at the specific complications that have been reported.

Step 4: practical points once treatment is underway

If treatment is approved, the practical steps are similar to those for anyone on a GLP-1 medicine, with one extra layer of dietary awareness. People without a gallbladder often find their digestion is more sensitive to large amounts of fat in a single sitting. GLP-1 medicines also reduce appetite significantly, so meal portions naturally become smaller; smaller, more frequent meals with moderate fat content generally sit more comfortably than one large fatty meal.

The early weeks of any GLP-1 treatment are typically when gastrointestinal side effects are most noticeable, nausea, loose stools, and digestive discomfort tend to ease as your body adjusts. Starting treatment at the lowest licensed dose and titrating slowly, guided by your prescriber, is how those effects are managed. Never adjust your dose or timing without clinical input; if side effects are making treatment difficult, that conversation belongs with your prescriber, not a dose change taken on your own initiative.

If you are also considering other routes to managing your weight and want to understand all available options, our weight loss overview sets out the full picture, including non-injection alternatives for people who would prefer to avoid injectable treatment. The treatment consultation page is where to start if you are ready to discuss suitability with a prescriber.